2clv: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
Line 1: Line 1:
[[Image:2clv.gif|left|200px]]
[[Image:2clv.gif|left|200px]]


{{Structure
<!--
|PDB= 2clv |SIZE=350|CAPTION= <scene name='initialview01'>2clv</scene>, resolution 1.90&Aring;
The line below this paragraph, containing "STRUCTURE_2clv", creates the "Structure Box" on the page.
|SITE=
You may change the PDB parameter (which sets the PDB file loaded into the applet)
|LIGAND=  
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
|ACTIVITY=  
or leave the SCENE parameter empty for the default display.
|GENE=
-->
|DOMAIN=
{{STRUCTURE_2clv| PDB=2clv  | SCENE= }}  
|RELATEDENTRY=
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2clv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2clv OCA], [http://www.ebi.ac.uk/pdbsum/2clv PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2clv RCSB]</span>
}}


'''MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE'''
'''MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE'''
Line 34: Line 31:
[[Category: Roussel, A.]]
[[Category: Roussel, A.]]
[[Category: Schmitt-Verhulst, A M.]]
[[Category: Schmitt-Verhulst, A M.]]
[[Category: alloreactivity]]
[[Category: Alloreactivity]]
[[Category: class i mhc]]
[[Category: Class i mhc]]
[[Category: glycoprotein]]
[[Category: Glycoprotein]]
[[Category: h-2kbm8]]
[[Category: H-2kbm8]]
[[Category: immune response]]
[[Category: Immune response]]
[[Category: immune system]]
[[Category: Immune system]]
[[Category: immunoglobulin domain]]
[[Category: Immunoglobulin domain]]
[[Category: membrane]]
[[Category: Membrane]]
[[Category: mhc i]]
[[Category: Mhc i]]
[[Category: polymorphism]]
[[Category: Polymorphism]]
[[Category: transmembrane]]
[[Category: Transmembrane]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 22:27:27 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 02:23:19 2008''

Revision as of 19:27, 3 May 2008

File:2clv.gif

Template:STRUCTURE 2clv

MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE


Overview

We have characterized three different programs of activation for alloreactive CD8 T cells expressing the BM3.3 TCR, their elicitation depending on the characteristics of the stimulating peptide/MHC complex. The high-affinity interaction between the TCR and the K(b)-associated endogenous peptide pBM1 (INFDFNTI) induced a complete differentiation program into effector cells correlated with sustained ERK activation. The K(bm8) variant elicited a partial activation program with delayed T cell proliferation, poor CTL activity and undetectable ERK phosphorylation; this resulted from a low-avidity interaction of TCR BM3.3 with a newly identified endogenous peptide, pBM8 (SQYYYNSL). Interestingly, mismatched pBM1/K(bm8) complexes induced a split response in BM3.3 T cells, with total reconstitution of T cell proliferation but defective generation of CTL activity that was correlated with strong but shortened ERK phosphorylation. Crystal structures highlight the molecular basis for the higher stability of pBM8/K(bm8) compared to pBM1/K(bm8) complexes that exist in two conformers. This study illustrates the importance of the stability of both peptide/MHC and peptide/MHC-TCR interactions for induction of sustained signaling required to induce optimal CTL effector functions. Subtle allelic structural variations, amplified by peptide selection, may thus orient distinct outcomes of alloreactive TCR-based therapies.

About this Structure

2CLV is a Protein complex structure of sequences from Mus musculus. Full crystallographic information is available from OCA.

Reference

Distinct orientation of the alloreactive monoclonal CD8 T cell activation program by three different peptide/MHC complexes., Auphan-Anezin N, Mazza C, Guimezanes A, Barrett-Wilt GA, Montero-Julian F, Roussel A, Hunt DF, Malissen B, Schmitt-Verhulst AM, Eur J Immunol. 2006 Jul;36(7):1856-66. PMID:16761314 Page seeded by OCA on Sat May 3 22:27:27 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=2clv&oldid=469708"